JournalClinical Journal of the American Society of Nephrology
PublisherAmerican Society of Nephrology
MetadataShow full item record
AbstractEnsuring patient safety is a priority of medical care because iatrogenic injury has been a primary concern. Medications are an important source ofmedical errors, and kidney disease is a thoroughfare of factors threatening safe administration of medicines. Principal among these is reduced kidney function because almost half of all medications used are eliminated via the kidney. Additionally, kidney patients often suffer from multimorbidity, including diabetes, hypertension, and heart failure, with a range of prescribers who often do not coordinate treatments. Patients with kidney disease are also susceptible to further kidney injury andmetabolic derangements from medications, which can worsen the disease. In this review, we will present the key issues and threats to safe medication use in kidney disease, with a focus on predialysis CKD, as the scope of medication safety in ESKD and transplantation are unique and deserve their own consideration. We discuss drugs that need to be avoided or dose modified, and reviewthe complications of a range ofmedications routinely administered in CKD, as these also call for cautious use. Copyright 2018 by the American Society of Nephrology.
SponsorsThis work was supported by Baltimore Veterans Affairs Patient Safety Center of Inquiry which is funded by the Veterans Affairs National Patient Center for Patient Safety in White River Junction, Vermont.
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85054559361&doi=10.2215%2fCJN.00580118&partnerID=40&md5=3f68e81bdf1a837c0e95d89cc90f18ad; http://hdl.handle.net/10713/9026
- Treatment of Abnormalities of Potassium Homeostasis in CKD.
- Authors: Palmer BF, Clegg DJ
- Issue date: 2017 Sep
- Hyperkalemia and Hypokalemia in CKD: Prevalence, Risk Factors, and Clinical Outcomes.
- Authors: Gilligan S, Raphael KL
- Issue date: 2017 Sep
- Antihypertensive Medication Use in Older Patients Transitioning from Chronic Kidney Disease to End-Stage Renal Disease on Dialysis.
- Authors: Chang TI, Zheng Y, Montez-Rath ME, Winkelmayer WC
- Issue date: 2016 Aug 8
- Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.
- Authors: Fang G, Annis IE, Farley JF, Mahendraratnam N, Hickson RP, Stürmer T, Robinson JG
- Issue date: 2018 Jan
- Effectiveness of patiromer in the treatment of hyperkalemia in chronic kidney disease patients with hypertension on diuretics.
- Authors: Weir MR, Mayo MR, Garza D, Arthur SA, Berman L, Bushinsky D, Wilson DJ, Epstein M
- Issue date: 2017 May